TE_178
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MIR |
|---|---|
| TE superfamily | L2-end |
| TE class | SINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 3.23 |
| Counts of samples | TCGA_tumor:62; TCGA_normal:11; GTEx:10 |
| TSS | chr1(-):18509617 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_178.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):18495471,18495491,18496015,18496857,18497496,18497549,18509570,18509618 |
| teRNA_178.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):18495471,18495491,18496015,18496857,18497496,18497546,18509570,18509618 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
